← Evidence map

ArticleCell cycle (Georgetown, Tex.)2017

Resistance to ALK inhibitors: Pharmacokinetics, mutations or bypass signaling?

Daniel B CostaPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2017
2018
2019
2020
2021
2022
2023
2024
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 27764548